Compression-Induced Polymorphic Transformation in Tablets: Role of Shear Stress and Development of Mitigation Strategies.
hydrostatic pressure
phase transformation
shear stress
tablet
viscoelastic excipients
Journal
Journal of pharmaceutical sciences
ISSN: 1520-6017
Titre abrégé: J Pharm Sci
Pays: United States
ID NLM: 2985195R
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
26
06
2018
revised:
24
08
2018
accepted:
14
09
2018
pubmed:
25
9
2018
medline:
18
2
2020
entrez:
25
9
2018
Statut:
ppublish
Résumé
Our goals were to evaluate the effects of (i) hydrostatic pressure alone and (ii) its combined effect with shear stress during compaction, on the polymorphic transformation (form C → A) of a model drug, chlorpropamide. The powder was either subjected to hydrostatic pressure in a pressure vessel or compressed in a tablet press, at pressures ranging from 25 to 150 MPa. The overall extent of phase transformation was determined by powder X-ray diffractometry, whereas 2D-X-ray diffractometry enabled quantification of the spatial distribution of phase composition in tablets. Irrespective of the pressure, the extent of transformation following compaction was higher than that because of hydrostatic pressure alone, the difference attributed to the contribution of shear stress experienced during compaction. At a compression pressure of 25 MPa, there was a pronounced gradient in the extent of phase transformation when monitored from radial tablet surface to core. This gradient decreased with increase in compression pressure. Four approaches were attempted to minimize the effect of compression-induced phase transformation: (a) site-specific lubrication, (b) use of a viscoelastic excipient, (c) ceramic-lined die, and (d) use of cavity tablet. The ceramic-lined die coupled with site-specific lubrication was most effective in minimizing the extent of compression-induced phase transformation.
Identifiants
pubmed: 30248335
pii: S0022-3549(18)30542-2
doi: 10.1016/j.xphs.2018.09.015
pii:
doi:
Substances chimiques
Excipients
0
Powders
0
Tablets
0
Chlorpropamide
WTM2C3IL2X
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
476-484Informations de copyright
Copyright © 2019 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.